Aristo Bio-Tech And Lifescience Limited — Board Meeting, 29-05-2025: Outcome of Board Meeting

Aristo Bio-Tech and Lifescience has announced a board meeting which approved the financial results for the quarter and half-year, along with audited standalone financials for FY25, receiving a clean audit opinion. The company plans a final dividend of Rs. 0.50 per share (5% of face value), pending shareholder approval. Management sees a key change as Company Secretary Ayushi Aditya Deora resigns, replaced immediately by Diksha Jaiprakash Peswani. The company remains focused on manufacturing and supplying agrochemical formulations.